COVID-19 Multifamily

RiskNomics (through its accredited and independent laboratory partners) is now able to offer environmental surface testing for SARS-CoV-2 (COVID-19) for our clients. This testing will evaluate the effectiveness of the products and processes used to decontaminate suspect surfaces.

Testing will confirm the presence/absence of the RNA genetic signature of the SARS-CoV-2 virus by swab samples from possibly contaminated environmental surfaces. While positive sample results indicate presence of the viral genetic SARS-CoV-2 nucleic material, test results may not definitively rule out the presence of other viral/bacterial contamination. Testing will also not indicate if the virus is still infectious, but only its presence/absence.

Note: Due to a current shortage of viral transport swabs, there may be some delays in testing availability turnaround times.